Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2022-03-14 00:00:00 ET · period of report 2022-03-11 · accession 0001171843-22-001833 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-14 | 2022-03-11 | ANIK | Blanchard Cheryl R | Pres, CEO, Dir | P - Purchase | $25.57 | +8,100 | 60.0K | +16% | +$207.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-11 | P | A | 4,287 | $25.36 | 56,179 | D | — | — | (F1) On March 11, 2022, Dr. Blanchard purchased 4,287 shares in multiple trades ranging from $24.69 to $25.69. The price reported above reflects the weighted average purchase price. Dr. Blanchard undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected. |
| 2 | Common | Common Stock | 2022-03-11 | P | A | 3,813 | $25.81 | 59,992 | D | — | — | (F2) On March 11, 2022, Dr. Blanchard purchased 3,813 shares in multiple trades ranging from $25.70 to $25.94. The price reported above reflects the weighted average purchase price. Dr. Blanchard undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected. |